Cite
APA Citation
Emery, P., Maini, R., Breedveld, F., Smolen, J., Kalden, J., Van der Heijde, D., Han, C., & Harriman, G. (n.d.). oP0087 Infliximab plus methotrexate inhibits structural damage, reduces sign and symptoms and improves disability in patients with active early rheumatoid arthritis. Annals of the rheumatic diseases, 60, A481–A482. http://access.bl.uk/ark:/81055/vdc_100137790145.0x00005f